The nuclear factor - Kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease

Thrombosis Research

Volumn 128, Issue 2, 2011, Pages 117-123

  Pamukcu, Burak ^a   Lip, Gregory Y H ^a   Shantsila, Eduard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; APIGENIN; AZADIRACHTIN; BMS 066; CAROTENOID; DIGITOXIN; EZETIMIBE; GEMFIBROZIL; GLUCOCORTICOID; I KAPPA B; LYCOPENE; RAPAMYCIN; UNCLASSIFIED DRUG; VINPOCETINE;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERY THROMBOSIS; ARTHRITIS; ASTHMA; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLITIS; ENTERITIS; HEART PROTECTION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MOLECULARLY TARGETED THERAPY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION MEDIATORS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 79960426739     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.03.025     Document Type: Review

References (109)

1. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 2002 725 734
2. M.S. Hayden, and S. Ghosh Shared principles in NF-kappaB signaling Cell 132 2008 344 362
3. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu Rev Immunol 18 2000 621 663 (Pubitemid 30365393)
4. U. Senftleben, Y. Cao, G. Xiao, F.R. Greten, G. Krähn, and G. Bonizzi Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 293 2001 1495 1499 (Pubitemid 32801552)
5. G.J. Nabel, and I.M. Verma Proposed NF-kappa B/I kappa B family nomenclature Genes Dev 7 1993 2063 (Pubitemid 23336133)
6. S. Basak, V.F. Shih, and A. Hoffmann Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system Mol Cell Biol 28 2008 3139 3150 (Pubitemid 351657080)
7. J.L. Pomerantz, and D. Baltimore Two pathways to NF-kappaB Mol Cell 10 2002 693 695
8. F. Mercurio, H. Zhu, B.W. Murray, A. Shevchenko, B.L. Bennett, and J. Li IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 278 1997 860 866 (Pubitemid 27467923)
9. M. Karin How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex Oncogene 18 1999 6867 6874
10. Z.J. Chen Ubiquitin signaling in the NF-κB pathway Nat Cell Biol 7 2005 758 765
11. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 2001 7 11 (Pubitemid 32047405)
12. Z. Chen, J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, and D. Ballard Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway Genes Dev 9 1995 1586 1597
13. M. Neumann, and M. Naumann Beyond IkappaBs: alternative regulation of NF-kappaB activity FASEB J 21 2007 2642 2654 (Pubitemid 47372732)
14. T. Kato Jr., M. Delhase, A. Hoffmann, and M. Karin CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response Mol Cell 12 2003 829 839 (Pubitemid 37352777)
15. Z.H. Wu, Y. Shi, R.S. Tibbetts, and S. Miyamoto Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli Science 311 2006 1141 1146
16. S. Janssens, A. Tinel, S. Lippens, and J. Tschopp PIDD mediates NF-kappaB activation in response to DNA damage Cell 123 2005 1079 1092 (Pubitemid 41785422)
17. G.M. Hur, J. Lewis, Q. Yang, Y. Lin, H. Nakano, and S. Nedospasov The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation Genes Dev 17 2003 873 882 (Pubitemid 36397375)
18. J. Bartek, and J. Lukas Cell biology. The stress of finding NEMO Science 311 2006 1110 1111
19. W. Zheng, R. Li, H. Pan, D. He, R. Xu, and T.B. Guo Role of osteopontin in induction of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1B through the NF-kB and MAPK pathways in rheumatoid arthritis Arthritis Rheum 60 2009 1957 1965
20. F. Oberg, A. Haseeb, M. Ahnfelt, F. Ponten, B. Westermark, and A. El-Obeida Herbal melanin activates TLR4/NF-kB signaling pathway Phytomedicine 16 2009 477 484
21. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
22. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 683 (Pubitemid 26130197)
23. M. Emmanouil, E. Taoufik, V. Tseveleki, S.S. Vamvakas, T. Tselios, and M. Karin Neuronal IkB Kinase B protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system J Immunol 183 2009 7877 7889
24. C.A. Nold-Petry, M.F. Nold, J.A. Zepp, S.H. Kim, N.F. Voelkel, and C.A. Dinarello IL-32-dependent effects of IL-1Beta on endothelial cell functions Proc Natl Acad Sci USA 106 2009 3883 3888
25. K. Leghmari, Y. Bennasser, and E. Bahraoui HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kB pathways Eur J Cell Biol 87 2008 947 962
26. M. Giannopoulou, C. Dai, X. Tan, X. Wen, G.K. Michalopoulos, and Y. Liu Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-κB signalling Am J Pathol 173 2008 30 41 (Pubitemid 351947953)
27. J.K. Min, Y.M. Lee, J.H. Kim, Y.M. Kim, S.W. Kim, and S.Y. Lee Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-κB pathway Circ Res 96 2005 300 307
28. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874 (Pubitemid 36019640)
29. M.C. Bourdillon, R.N. Poston, C. Covacho, E. Chignier, G. Bricca, and J.L. McGregor ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE-/-/ICAM-1-/-) fed a fat or a chow diet Arterioscler Thromb Vasc Biol 20 2000 2630 2635
30. Y. Nakashima, E.W. Raines, A.S. Plump, J.L. Breslow, and R. Ross Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse Arterioscler Thromb Vasc Biol 18 1998 842 851 (Pubitemid 28267666)
31. M.I. Cybulsky, K. Iiyama, H. Li, S. Zhu, M. Chen, and M. Iiyama A major role for VCAM-1, but not ICAM-1, in early atherosclerosis J Clin Invest 107 2001 1255 1262 (Pubitemid 32494542)
32. F. Merhi-Soussi, B.R. Kwak, D. Magne, C. Chadjichristos, M. Berti, and G. Pelli Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice Cardiovasc Res 66 2005 583 593 (Pubitemid 40725770)
33. R.G. Collins, R. Velji, N.V. Guevara, M.J. Hicks, L. Chan, and A.L. Beaudet P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice J Exp Med 191 2000 189 194 (Pubitemid 30043660)
34. L. Gu, Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, and P. Libby Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol Cell 2 1998 275 281 (Pubitemid 128373654)
35. C. Tikellis, K.A. Jandeleit-Dahm, K. Sheehy, A. Murphy, J. Chin-Dusting, and D. Kling Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with down regulation of adhesion molecules Atherosclerosis 199 2008 55 64
36. R.C. Johnson, S.M. Chapman, Z.M. Dong, J.M. Ordovas, T.N. Mayadas, and J. Herz Absence of P-selectin delays fatty streak formation in mice J Clin Invest 99 1997 1037 1043 (Pubitemid 27123641)
37. R. Gareus, E. Kotsaki, S. Xanthoulea, I. van der Made, M.J.J. Gijbels, and R. Kardakaris Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis Cell Metab 8 2008 372 383
38. A.R. Brasier The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation Cardiovasc Res 86 2010 211 218
39. A. Zernecke, and C. Weber Chemokines in the vascular inflammatory response of atherosclerosis Cardiovasc Res 86 2010 192 201
40. A. Di Lorenzo, T.D. Manes, A. Davalos, P.L. Wright, and W.C. Sessa Endothelial reticulon-4B (Nogo-B) regulates ICAM-1-mediated leukocyte transmigration and acute inflammation Blood 117 2011 2284 2295
41. C. Monaco, E. Andreakos, S. Kiriakidis, C. Mauri, C. Bicknell, and B. Foxwell Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis Proc Natl Acad Sci USA 101 2004 5634 5639 (Pubitemid 38481208)
42. S. Cuhlmann, K. Van der Heiden, D. Saliba, J.L. Tremoleda, M. Khalil, and M. Zakkar Disturbed Blood Flow Induces RelA Expression via c-Jun N-Terminal Kinase 1: A Novel Mode of NF-{kappa}B Regulation That Promotes Arterial Inflammation Circ Res 2011 Feb 24. [Epub ahead of print] PMID: 21350211.
43. B. Pamukcu, G.Y. Lip, A. Devitt, H. Griffiths, and E. Shantsila The role of monocytes in atherosclerotic coronary artery disease Ann Med 42 2010 394 403
44. Y. Lu, and L.M. Wahl Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/ IKKα/NF-κB pathway J Leukoc Biol 78 2005 259 265 (Pubitemid 40979965)
45. T. Bourcier, G. Sukhova, and P. Libby The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis J Biol Chem 272 1997 15817 15824 (Pubitemid 27265559)
46. T. Muroya, Y. Ihara, S. Ikeda, C. Yasuoka, Y. Miyahara, and Y. Urata Oxidative modulation of NF-kappaB signaling by oxidized low-density lipoprotein Biochem Biophys Res Commun 309 2003 900 905 (Pubitemid 37122614)
47. T.W. Kim, M. Febbraio, P. Robinet, B. Dugar, D. Greene, and A. Cerny The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-{kappa}B Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atherosclerosis J Immunol 186 2011 2871 2880
48. F. Robbesyn, R. Salvayre, and A. Negre-Salvayre Dual role of oxidized LDL on the NF-kappaB signaling pathway Free Radic Res 38 2004 541 551 (Pubitemid 38697088)
49. F. Bussolino, A. Mantovani, and G. Persico Molecular mechanisms of blood vessel formation Trends Biochem Sci 22 1997 251 256 (Pubitemid 27310945)
50. D. Ribatti, F. Levi-Schaffer, and P.T. Kovanen Infl ammatory angiogenesis in atherogenesis - a double-edged sword Ann Med 40 2008 606 621
51. J.M. Lambert, E.F. Lopez, and M.L. Lindsey Macrophage roles following myocardial infarction Int J Cardiol 130 2008 147 158
52. C. Murdoch, S. Tazzyman, S. Webster, and C.E. Lewis Expression of Tie-2 by human monocytes and their responses to angiopoietin-2 J Immunol 178 2007 7405 7411 (Pubitemid 46847468)
53. C. Morais, G. Gobe, D.W. Johnson, and H. Healy Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor Angiogenesis 12 2009 365 379
54. T.A. Zaichuk, E.H. Shroff, R. Emmanuel, S. Filleur, T. Nelius, and O.V. Volpert Nuclear factor of activated T cells balances angiogenesis activation and inhibition J Exp Med 199 2004 1513 1522 (Pubitemid 38780406)
55. A.B. Aurora, D. Biyashev, Y. Mirochnik, T.A. Zaichuk, C. Sanchez-Martinez, and M.A. Renault NF-kB balances vascular regression and angiogenesis via chromatin remodelling and NFAT displacement Blood 116 2010 475 484
56. B. Li, Y.Y. Li, S.W. Tsao, and A.L.M. Cheung Targeting NF-κB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer Mol Cancer Ther 8 2009 2635 2644
57. J.L. Luo, H. Kamata, and M. Karin IKK/NF-kB signaling: balancing life and death - a new approach to cancer therapy J Clin Invest 115 2005 2625 2632 (Pubitemid 41434385)
58. C. Bubici, S. Papa, C.G. Pham, F. Zazzeroni, and G. Franzoso NF-kB and JNK: an intricate affair Cell Cycle 3 2004 1524 1529
59. S. Papa, C. Bubici, F. Zazzeroni, C.G. Pham, C. Kuntzen, and J.R. Knabb The NF-kB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease Cell Death Differ 13 2006 712 729
60. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 2002 725 734
61. L. Ottonello, M. Bertolotto, F. Montecucco, G. Bianchi, and F. Dallegri Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkB kinase/nuclear factor kB pathway Br J Pharmacol 157 2009 294 306
62. J. Kucharczak, M.J. Simmons, Y. Fan, and C. Gelinas To be, or not to be: NF-kB is the answer - role of Rel/NF-kB in the regulation of apoptosis Oncogene 56 2003 8961 8982 (Pubitemid 38121698)
63. A. Kumar, Y. Takada, A.M. Boriek, and B.B. Aggarwal Nuclear factor-kB: its role in health and disease J Mol Med 82 2004 434 448 (Pubitemid 39044283)
64. H. Liu, and R.M. Pope The role of apoptosis in rheumatoid arthritis Curr Opin Pharmacol 3 2003 317 322 (Pubitemid 36686774)
65. S.E. Shoelson, J. Lee, and M. Yuan Inflammation and the IKKb/IkB/NFkB axis in obesity- and diet-induced insulin resistance Int J Obes Relat Metab Disord 3 2003 S49 S52
66. P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation Circulation 111 2005 1448 1454 (Pubitemid 40396812)
67. S. Kasibhatla, T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D.R. Green DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1 Mol Cell 1 1998 543 551 (Pubitemid 128374690)
68. E.P. Cummins, E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, and F. Seeballuck Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity Proc Natl Acad Sci USA 103 2006 18154 18159 (Pubitemid 44871628)
69. A.C. Koong, E.Y. Chen, N.F. Mivechi, N.C. Denko, P. Stambrook, and A.J. Giaccia Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2) Cancer Res 54 1994 5273 5279 (Pubitemid 24336013)
70. S.R. Walmsley, C. Print, N. Farahi, C. Peyssonnaux, R.S. Johnson, and T. Cramer Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity J Exp Med 201 2005 105 115 (Pubitemid 40130088)
71. Y. Takada, A. Mukhopadhyay, G.C. Kundu, G.H. Mahabeleshwar, S. Singh, and B.B. Aggarwal Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase J Biol Chem 278 2003 24233 24241 (Pubitemid 36830260)
72. N.C. Moss, R.H. Tang, M. Willis, W.E. Stansfield, A.S. Baldwin, and C.H. Selzman Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection J Thorac Cardiovasc Surg 136 2008 1274 1279
73. G. Liuzzo, M. Santamaria, L.M. Biasucci, M. Narducci, V. Colafrancesco, and A. Porto Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide- free C-reactive protein on human monocytes via nuclear factor kappa-B activation J Am Coll Cardiol 49 2007 185 194 (Pubitemid 46054391)
74. Y.J. Chen, L.Q. Zhang, G.P. Wang, H. Zeng, B. Lü, and X.L. Shen Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells Thromb Haemost 100 2008 291 300
75. D.J. Jiang, Y. Cao, H.Y. Xin, X.H. Li, Z.Q. Luo, and Y.J. Li Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes Atherosclerosis 205 2009 554 560
76. J. Frässdorf, N.C. Weber, D. Obal, O. Toma, J. Müllenheim, and G. Kojda Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB Anesth Analg 101 2005 934 941 (Pubitemid 41383050)
77. C. Monaco, and E. Paleolog Nuclear factor nB: a potential therapeutic target in atherosclerosis and thrombosis Cardiovasc Res 61 2004 671 682 (Pubitemid 38249466)
78. C.T. Esmon Crosstalk between inflammation and thrombosis Maturitas 61 2008 122 131
79. J.S. Ross, N.E. Stagliano, M.J. Donovan, R.E. Breitbart, and G.S. Ginsburg Atherosclerosis: a cancer of the blood vessels? Am J Clin Pathol 116 2001 S97 S107
80. R. Kollander, A. Solovey, L.C. Milbauer, F. Abdulla, R.J. Kelm Jr., and R.P. Hebbel Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease Transl Res 155 2010 170 177
81. D. Song, X. Ye, H. Xu, and S.F. Liu Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice Blood 114 2009 2521 2529
82. X. Ye, J. Ding, X. Zhou, G. Chen, and S.F. Liu Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis J Exp Med 205 2008 1303 1315 Erratum in J Exp Med 2008; 205: 1509. (Pubitemid 351831488)
83. J.E. Wiggins, S.R. Patel, K.A. Shedden, M. Goyal, B.L. Wharram, and S. Martini NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus J Am Soc Nephrol 21 2010 587 597
84. Y. Chen, J. Wang, Y. Yao, W. Yuan, M. Kong, and Y. Lin CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway FEBS Lett 583 2009 2811 2818
85. M. Thoh, P. Kumar, H.A. Nagarajaram, and S.K. Manna Azadirachtin interacts with the tumor necrosis factor (TNF) binding domain of its receptors and inhibits TNF-induced biological responses J Biol Chem 285 2010 5888 5895
86. K.W. McIntyre, D.J. Shuster, K.M. Gillooly, D.M. Dambach, M.A. Pattoli, and P. Lu A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice Arthritis Rheum 48 2003 2652 2659 (Pubitemid 37129443)
87. K.M. Gillooly, M.A. Pattoli, T.A. Taylor, L. Chen, L. Cheng, and K.R. Gregor Periodic, partial inhibition of IkB Kinase B-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis JPET 331 2009 349 360
88. D. Heber, and Q.Y. Lu Overview of mechanisms of action of lycopene Exp Biol Med (Maywood) 227 2002 920 923 (Pubitemid 35340348)
89. T. Rissanen, S. Voutilainen, K. Nyyssönen, R. Salonen, and J.T. Salonen Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall Arterioscler Thromb Vasc Biol 20 2000 2677 2681
90. J.H. Dwyer, M.J. Paul-Labrador, J. Fan, A.M. Shircore, C.N. Merz, and K.M. Dwyer Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study Arterioscler Thromb Vasc Biol 24 2004 313 319 (Pubitemid 38197584)
91. Y.E. Joo, T. Karrasch, M. Mühlbauer, B. Allard, A. Narula, H.H. Herfarth, and C. Jobin Tomato lycopene extract prevents lipopolysaccharide- induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice PLoS One 4 2009 e4562
92. D. Feng, W.H. Ling, and R.D. Duan Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages Inflamm Res 59 2010 115 121
93. C. Nicholas, S. Batra, M.A. Vargo, O.H. Voss, M.A. Gavrilin, M.D. Wewers, D.C. Guttridge, E. Grotewold, and A.I. Doseff Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation J Immunol 179 2007 7121 7127
94. A. Ferrante, B.S. Robinson, H. Singh, H.P.A. Jersmann, J.V. Ferrante, Z.H. Huang, N.A. Trout, M.J. Pitt, D.A. Rathjen, C.J. Easton, A. Poulos, R.H. Prager, F.S. Lee, and C.S.T. Hii A novel β-Oxa polyunsaturated fatty acid downregulates the activation of the IκB kinase/nuclear factor κB pathway, inhibits expression of endothelial cell adhesion molecules, and depresses inflammation Circ Res 99 2006 34 41 (Pubitemid 44297053)
95. K.I. Jeon, X. Xu, T. Aizawa, J.H. Lim, H. Jono, D.S. Kwon, J. Abe, B.C. Berk, J.D. Li, and C. Yan Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism Proc Natl Acad Sci USA 107 2010 9795 9800
96. J. Jagielska, G. Salguero, B. Schieffer, and U. Bavendiek Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis? Atherosclerosis 206 2009 390 396
97. D. Gómez-Garre, P. Muñoz-Pacheco, M.L. González- Rubio, P. Aragoncillo, R. Granados, and A. Fernández-Cruz Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect Br J Pharmacol 156 2009 1218 1227
98. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosupprcssion by glucocorticoids: Inhibition of NF-KB activity through induction of IKB synthesis Science 270 1995 286 290
99. A. Tiran, H.J. Gruber, W.F. Graier, A.H. Wagner, E.B. Van Leeuwen, and B. Tiran Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells Arterioscler Thromb Vasc Biol 22 2002 1075 1080 (Pubitemid 34764855)
100. T. Yotsui, O. Yasuda, H. Kawamoto, M. Higuchi, Y. Chihara, E. Umemoto, T. Tanaka, M. Miyasaka, H. Rakugi, and T. Ogihara Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells FEBS Lett 581 2007 427 432 (Pubitemid 46149614)
101. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, I.P. Torra, P. Delerive, A. Fadel, G. Chinetti, J.C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators Nature 393 1998 790 793 (Pubitemid 28299490)
102. V. Ollivier, S. Hammal, N. Ameziane, M.T. Labro, and D. de Prost Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells Thromb Haemost 94 2005 46 52 (Pubitemid 40974704)
103. S.F. Luo, R.Y. Fang, H.L. Hsieh, P.L. Chi, C.C. Lin, L.D. Hsiao, C.C. Wu, J.S. Wang, and C.M. Yang Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts Arthritis Rheum 62 2010 105 116
104. A. Tsuchiya, K. Imai, K. Asamitsu, Y. Waguri-Nagaya, T. Otsuka, and T. Okamoto Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor J Pharmacol Exp Ther 333 2010 236 243
105. J.G. Wright, and J.W. Christman The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy Am J Respir Med 2 2003 211 219 (Pubitemid 36869436)
106. K.F. Chung Cytokines as targets in chronic obstructive pulmonary disease Curr Drug Targets 7 2006 675 681 (Pubitemid 43827263)
107. K.J. Cho, J.M. Seo, Y. Shin, M.H. Yoo, C.S. Park, S.H. Lee, Y.S. Chang, S.H. Cho, and J.H. Kim Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor Am J Respir Cell Mol Biol 42 2010 294 303
108. M.F. Neurath, I. Fuss, G. Schürmann, S. Pettersson, K. Arnold, H. Müller-Lobeck, W. Strober, C. Herfarth, and K.H. Büschenfelde Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease Ann NY Acad Sci 859 1998 149 159 (Pubitemid 29021014)
109. S.N. Giraud, C.M. Caron, D. Pham-Dinh, P. Kitabgi, and A.B. Nicot Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes Proc Natl Acad Sci USA 107 2010 8416 8421